Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00567554 |
|---|---|
| Brief Title: | Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer (GeparQuinto) |
| First Submitted : | December 4, 2007 |
| First Submitted that Met QC Criteria : | December 4, 2007 |
| First Posted : | December 5, 2007 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 9, 2016 |
| Last Update Posted : | February 10, 2016 (Estimate) |